Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 182

1.

HLA-B7-restricted EBV-specific CD8+ T cells are dysregulated in multiple sclerosis.

Jilek S, Schluep M, Harari A, Canales M, Lysandropoulos A, Zekeridou A, Pantaleo G, Du Pasquier RA.

J Immunol. 2012 May 1;188(9):4671-80. doi: 10.4049/jimmunol.1103100. Epub 2012 Mar 28.

2.

Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes.

Tan LC, Mowat AG, Fazou C, Rostron T, Roskell H, Dunbar PR, Tournay C, Romagné F, Peyrat MA, Houssaint E, Bonneville M, Rickinson AB, McMichael AJ, Callan MF.

Arthritis Res. 2000;2(2):154-64. Epub 2000 Feb 7.

3.

Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.

Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.

Brain. 2008 Jul;131(Pt 7):1712-21. doi: 10.1093/brain/awn108. Epub 2008 Jun 11.

PMID:
18550621
4.
5.

Rapid reconstitution of Epstein-Barr virus-specific T lymphocytes following allogeneic stem cell transplantation.

Marshall NA, Howe JG, Formica R, Krause D, Wagner JE, Berliner N, Crouch J, Pilip I, Cooper D, Blazar BR, Seropian S, Pamer EG.

Blood. 2000 Oct 15;96(8):2814-21.

6.

Expansion of peripheral CD8+ CD28- T cells in response to Epstein-Barr virus in patients with rheumatoid arthritis.

Klatt T, Ouyang Q, Flad T, Koetter I, Bühring HJ, Kalbacher H, Pawelec G, Müller CA.

J Rheumatol. 2005 Feb;32(2):239-51.

PMID:
15693083
7.

Differential evolution and stability of epitope-specific CD8(+) T cell responses in EBV infection.

Catalina MD, Sullivan JL, Bak KR, Luzuriaga K.

J Immunol. 2001 Oct 15;167(8):4450-7. Erratum in: J Immunol 2001 Nov 15;167(10):6045.

8.

Identification of Epstein-Barr virus-specific CD8+ T lymphocytes in the circulation of pediatric transplant recipients.

Falco DA, Nepomuceno RR, Krams SM, Lee PP, Davis MM, Salvatierra O, Alexander SR, Esquivel CO, Cox KL, Frankel LR, Martinez OM.

Transplantation. 2002 Aug 27;74(4):501-10.

PMID:
12352909
9.

Defective control of latent Epstein-Barr virus infection in systemic lupus erythematosus.

Kang I, Quan T, Nolasco H, Park SH, Hong MS, Crouch J, Pamer EG, Howe JG, Craft J.

J Immunol. 2004 Jan 15;172(2):1287-94.

10.

Phenotypic and functional heterogeneity of EBV epitope-specific CD8+ T cells.

Catalina MD, Sullivan JL, Brody RM, Luzuriaga K.

J Immunol. 2002 Apr 15;168(8):4184-91.

11.

Longitudinal analysis of frequency and reactivity of Epstein-Barr virus-specific T lymphocytes and their association with intermittent viral reactivation.

Vogl BA, Fagin U, Nerbas L, Schlenke P, Lamprecht P, Jabs WJ.

J Med Virol. 2012 Jan;84(1):119-31. doi: 10.1002/jmv.22258.

PMID:
22095540
13.

Gene-environment interactions between HLA B7/A2, EBV antibodies are associated with MRI injury in multiple sclerosis.

Zivadinov R, Weinstock-Guttman B, Zorzon M, Uxa L, Serafin M, Bosco A, Bratina A, Maggiore C, Grop A, Tommasi MA, Srinivasaraghavan B, Ramanathan M.

J Neuroimmunol. 2009 Apr 30;209(1-2):123-30. doi: 10.1016/j.jneuroim.2009.01.023. Epub 2009 Feb 15.

PMID:
19232441
14.

Frequency analysis of HLA-B7-restricted Epstein-Barr virus-specific cytotoxic T lymphocytes in patients with multiple sclerosis and healthy controls.

Gronen F, Ruprecht K, Weissbrich B, Klinker E, Kroner A, Hofstetter HH, Rieckmann P.

J Neuroimmunol. 2006 Nov;180(1-2):185-92. Epub 2006 Oct 4.

PMID:
17023054
15.

Identification of vaccinia CD8+ T-cell epitopes conserved among vaccinia and variola viruses restricted by common MHC class I molecules, HLA-A2 or HLA-B7.

Terajima M, Cruz J, Leporati AM, Demkowicz WE Jr, Kennedy JS, Ennis FA.

Hum Immunol. 2006 Jul;67(7):512-20. Epub 2006 May 4.

PMID:
16829305
16.
17.

Use of HLA-B27 tetramers to identify low-frequency antigen-specific T cells in Chlamydia-triggered reactive arthritis.

Appel H, Kuon W, Kuhne M, Wu P, Kuhlmann S, Kollnberger S, Thiel A, Bowness P, Sieper J.

Arthritis Res Ther. 2004;6(6):R521-34. Epub 2004 Sep 23.

18.

EBV-specific CD8+ T cell memory: relationships between epitope specificity, cell phenotype, and immediate effector function.

Hislop AD, Gudgeon NH, Callan MF, Fazou C, Hasegawa H, Salmon M, Rickinson AB.

J Immunol. 2001 Aug 15;167(4):2019-29.

19.

Most antiviral CD8 T cells during chronic viral infection do not express high levels of perforin and are not directly cytotoxic.

Zhang D, Shankar P, Xu Z, Harnisch B, Chen G, Lange C, Lee SJ, Valdez H, Lederman MM, Lieberman J.

Blood. 2003 Jan 1;101(1):226-35. Epub 2002 Aug 22.

20.

An age-related increase in the number of CD8+ T cells carrying receptors for an immunodominant Epstein-Barr virus (EBV) epitope is counteracted by a decreased frequency of their antigen-specific responsiveness.

Ouyang Q, Wagner WM, Walter S, Müller CA, Wikby A, Aubert G, Klatt T, Stevanovic S, Dodi T, Pawelec G.

Mech Ageing Dev. 2003 Apr;124(4):477-85.

PMID:
12714256

Supplemental Content

Support Center